- Home
- BORR vs TRVI Comparison
BORR vs TRVI Comparison
Compare BORR & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BORR | TRVI |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BORR | TRVI |
|---|---|---|
| Price | $4.30 | $10.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 12 |
| Target Price | $4.60 | ★ $20.38 |
| AVG Volume (30 Days) | ★ 4.4M | 1.4M |
| Earning Date | 02-18-2026 | 11-13-2025 |
| Dividend Yield | ★ 0.47% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $1,024,500,000.00 | N/A |
| Revenue This Year | $1.03 | N/A |
| Revenue Next Year | $1.76 | N/A |
| P/E Ratio | $15.21 | ★ N/A |
| Revenue Growth | ★ 5.83 | N/A |
| 52 Week Low | $1.55 | $3.47 |
| 52 Week High | $4.55 | $14.39 |
Technical Indicators
Market Signals| Indicator | BORR | TRVI |
|---|---|---|
| Relative Strength Index (RSI) | 59.71 | 33.19 |
| Support Level | $4.17 | $10.99 |
| Resistance Level | $4.55 | $11.78 |
| Average True Range (ATR) | 0.18 | 0.67 |
| MACD | 0.00 | -0.16 |
| Stochastic Oscillator | 62.14 | 0.19 |
Price Performance
Historical ComparisonAbout BORR Borr Drilling Limited
Borr Drilling Ltd is a drilling contractor that owns and operates jack-up rigs of modern and high-specification designs providing drilling services to the oil and gas exploration and production industry. The company operates a fleet of around 16 jack-up drilling rigs. Geographically the activities are carried out through Norway.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.